Sakar Healthcare Limited — Important, 13-12-2024: General Updates

Sakar Healthcare Limited has been recognized among the Top 10 Oncology Drug Manufacturers for 2024 by India Pharma Outlook. This recognition highlights the company's research-driven, EU GMP-approved oncology unit, where they produce a range of formulations, including oral solids and injectable products. The facility is equipped with advanced technology and adheres to strict regulatory guidelines. As Sakar expands its business development efforts globally, particularly in licensing European-standard dossiers, this accreditation is poised to enhance both domestic and international partner confidence. The ranking will not only boost the company’s reputation in the oncology sector but is expected to contribute positively to both revenue and profitability in the coming quarters.